pe
pep-05331 v1 CC-BY-SA-4.0

SPAG11A anticancer peptide

A lab-studied peptide being explored for its potential to kill cancer cells; experimental, not an approved drug.

statuscomputed targetANTICANCER length49 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.755
avg pLDDT86.9
ranking score0.846
STRUCTURE · PEP-05331 × ANTICANCER
ranking0.846
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence49 aa
15101520253035404549
DIPPGIR NTVCFMQ RGHCRLF MCRSGER KGDICSD PWNRCCV SSSIKNR
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.846249520778656 boltz-2
3-letter notation
Asp-Ile-Pro-Pro-Gly-Ile-Arg-Asn-Thr-Val-Cys-Phe-Met-Gln-Arg-Gly-His-Cys-Arg-Leu-Phe-Met-Cys-Arg-Ser-Gly-Glu-Arg-Lys-Gly-Asp-Ile-Cys-Ser-Asp-Pro-Trp-Asn-Arg-Cys-Cys-Val-Ser-Ser-Ser-Ile-Lys-Asn-Arg
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). SPAG11A anticancer peptide (pep-05331, v1). PeptideModel. https://peptidemodel.com/card/pep-05331
@peptide{pep05331,
  sequence = {DIPPGIRNTVCFMQRGHCRLFMCRSGERKGDICSDPWNRCCVSSSIKNR},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use